Steven D Rubin insider trades
Open-market stock purchases and sales by Steven D Rubin, Executive VP-Administration at Opko Health, Inc, from SEC Form 4 filings since Jan 11, 2010.
Track record: 23% of 22 scored buys are up 5% or more since purchase, averaging -36%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 7, 2026 | Entera Bio Ltd | Bought (not open market) | — |
| Aug 7, 2026 | Entera Bio Ltd | Bought (not open market) | — |
| Aug 7, 2026 | Entera Bio Ltd | Bought (not open market) | — |
| Jul 24, 2026 | OPK Opko Health, Inc | Sold (not open market) | $65K |
| Jun 24, 2026 | NAGE Niagen Bioscience, Inc | Bought (not open market) | — |
| Jun 8, 2026 | ELOX Eloxx Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 4, 2026 | RDVT Red Violet, Inc | Bought (not open market) | — |
| Feb 12, 2026 | [ENTX] Entera Bio Ltd | Bought | $7.5K |
| Feb 9, 2026 | [ENTX] Entera Bio Ltd | Bought | $12K |
| Jan 24, 2026 | ELOX Eloxx Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 9, 2026 | COCP Cocrystal Pharma, Inc | Bought (not open market) | — |
| Dec 19, 2025 | RDVT Red Violet, Inc | Bought (not open market) | — |
Companies traded
- OPK Opko Health, Inc: 20 buys, 2 sales, last Jul 24, 2026
- NAGE Niagen Bioscience, Inc: other filings, last Jun 24, 2026
- ELOX Eloxx Pharmaceuticals, Inc: other filings, last Jun 8, 2026
- RDVT Red Violet, Inc: 1 sale, last Jun 4, 2026
- [ENTX] Entera Bio Ltd: 2 buys, last Feb 12, 2026
- COCP Cocrystal Pharma, Inc: 3 buys, last Jan 9, 2026
- CDXC ChromaDex Corp: 1 buy, last Jun 20, 2024
- ROX Castle Brands Inc: other filings, last Oct 8, 2019
- VBIV VBI Vaccines Inc/BC: other filings, last Jun 14, 2018
- SVOND Sevion Therapeutics, Inc: other filings, last Dec 19, 2017
- COGT Cogint, Inc: other filings, last Apr 13, 2017
- SVON Sevion Therapeutics, Inc: other filings, last Feb 14, 2017